HuagongsheHuagongshe Chemistry Print Report · For research reference only
Piperazine Dihydrochloride → Irbesartan
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Piperazine Dihydrochloride | HCID 8893 | — |
| Reactant | Sodium Azide | HCID 33557 | — |
| Reactant | 4'-((2-Butyl-4-oxo-1,3-diazaspiro(4.4)non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile | HCID 9843116 | — |
| Solvent | O-Xylene | HCID 7237 | — |
| Product | Irbesartan | HCID 3749 | 96% |
Reaction Steps
A mixture of 2-n-butyl-3-[(2′-cyanobiphenyl-4-yl)methyl]-1,3-diazaspiro-[4,4]-non-1-en-4-one (10 g), sodium azide (7.7 g) and piperazine dihydrochloride (7.5 g) in xylene (30 ml) was refluxed for 7 hours under stirring. The reaction was cooled to room temperature and extracted with 5% NaOH solution. The pooled alkaline solution was washed with toluene or xylene (15 ml) and the aqueous phase neutralized to pH 6.5 using concentrated HCL. The resulting suspension was stirred for 3 hours at room temperature and filtered obtain irbesartan (3.6 g, 96% purity by HPLC).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08080670B2 |
| Source dataset | uspto-grants-2011_12 |
| ORD ID | ord-a67296b3abe540c4a17ddd7e7fd19fb6 |
| Source note | uspto-grants-2011_12 |